TDGF1 Produkte
(Teratocarcinoma-Derived Growth Factor 1 (TDGF1))
Kategorien
This gene encodes an epidermal growth factor-related protein that contains a cripto, FRL-1, and cryptic domain. The encoded protein is an extracellular, membrane-bound signaling protein that plays an essential role in embryonic development and tumor growth. Mutations in this gene are associated with forebrain defects. Pseudogenes of this gene are found on chromosomes 2, 3, 6, 8, 19 and X. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010].
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte TDGF1 Kategorien
TDGF1 Antikörper
High quality antibodies with extensive validation data.
TDGF1 ELISA Kits
Reliable ELISA kits for a wide range of species.
TDGF1 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene TDGF1 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IHC
Validierungen
- (5)
Kat. Nr.
ABIN3021342
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human, Mouse, Rat
Applikation
IHC
Validierungen
- (3)
Kat. Nr.
ABIN7007414
Menge
60 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IHC (p)
Validierungen
- (2)
Kat. Nr.
ABIN388791
Menge
400 μL
Datenblatt
Datenblatt
Empfohlene TDGF1 ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Mouse
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6970586
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Rat
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6970587
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Sandwich ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6959889
Menge
96 tests
Datenblatt
Datenblatt
Empfohlene TDGF1 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1322428
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Rat
Source
HEK-293 Cells
Validierungen
- (1)
Kat. Nr.
ABIN7198209
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
HEK-293 Cells
Validierungen
Kat. Nr.
ABIN7504538
Menge
100 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren TDGF1 Produkten
: "An evaluation of different Cripto-1 antibodies and their variable results." in: Journal of cellular biochemistry, (2019) (PubMed).: "MicroRNA-15b suppresses the growth and invasion of glioma cells through targeted inhibition of cripto-1 expression." in: Molecular medicine reports, Vol. 13, Issue 6, pp. 4897-903, (2016) (PubMed).
: "GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer." in: Cancer research and treatment : official journal of Korean Cancer Association, Vol. 47, Issue 4, pp. 804-12, (2015) (PubMed).
: "Autoregulation and heterogeneity in expression of human Cripto-1." in: PLoS ONE, Vol. 10, Issue 2, pp. e0116748, (2015) (PubMed).
: "Lefty inhibits glioma growth by suppressing Nodal-activated Smad and ERK1/2 pathways." in: Journal of the neurological sciences, Vol. 347, Issue 1-2, pp. 137-42, (2014) (PubMed).
: "Growth factor induction of Cripto-1 shedding by glycosylphosphatidylinositol-phospholipase D and enhancement of endothelial cell migration." in: The Journal of biological chemistry, Vol. 282, Issue 43, pp. 31643-55, (2007) (PubMed).
: "Requirement of glycosylphosphatidylinositol anchor of Cripto-1 for trans activity as a Nodal co-receptor." in: The Journal of biological chemistry, Vol. 282, Issue 49, pp. 35772-86, (2007) (PubMed).
: "Cripto: a novel target for antibody-based cancer immunotherapy." in: Cancer research, Vol. 64, Issue 11, pp. 4018-23, (2004) (PubMed).
: "Cripto forms a complex with activin and type II activin receptors and can block activin signaling." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Issue 9, pp. 5193-8, (2003) (PubMed).
: "Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells." in: The Journal of cell biology, Vol. 163, Issue 2, pp. 303-14, (2003) (PubMed).
Synonyme und alternative Namen zu TDGF1
teratocarcinoma-derived growth factor 1 (TDGF1), teratocarcinoma-derived growth factor 1 (Tdgf1), teratocarcinoma-derived growth factor 1 (tdgf1), teratocarcinoma-derived growth factor 1, member 3 L homeolog (tdgf1.3.L), teratocarcinoma-derived growth factor 1, member 1 (tdgf1.1), cb85, CR, CR1, cr1, cr1a, CRGF, CRIPTO, cripto, Cripto-1, cripto-3, frl-1, frl1, tdgf1, TDGF1, tdgf3, wu:fe01d04, xcr1, zgc:109829Bezeichner auf Proteinebene für TDGF1
- cripto-1 growth factor
- epidermal growth factor-like cripto protein CR1
- TERATOCARCINOMA-DERIVED GROWTH FACTOR PRECURSOR (EPIDERMAL GROWTH FACTOR-LIKE CRIPTO PROTEIN) (CRIPTO GROWTH FACTOR)
- cripto growth factor
- epidermal growth factor-like Cripto protein
- teratocarcinoma-derived growth factor
- cryptic protein
- one eyed pinhead
- teratocarcinoma-derived growth factor 1
- cripto-1a
- fibroblast growth factor receptor ligand 1
- teratocarcinoma-derived growth factor 3
Haben Sie etwas anderes gesucht?
Sie sind hier:
